LUCD - Lucid Diagnostics Inc.
Lucid Diagnostics Inc.
360 Madison Avenue
25th Floor
New York, NY 10017
United States
212 949 4319
https://www.luciddx.com
Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees:
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Lishan Aklog M.D. | Chairman & CEO | N/A | N/A | 1966 |
| Mr. Dennis M. McGrath CPA | Chief Financial Officer | N/A | N/A | 1957 |
| Mr. Shaun M. O'Neill M.B.A. | Exec. VP & COO | N/A | N/A | 1982 |
| Dr. Sanford D. Markowitz M.D., Ph.D. | Cofounder & Strategic Advisor, Member of the Medical Advisor Board | 14.54k | N/A | N/A |
| Dr. Joseph Willis M.D. | Cofounder, Strategic Advisor & Member of Medical Advisory Board | N/A | N/A | N/A |
| Dr. Amitabh Chak M.D. | Cofounder, Strategic Advisor & Member of Medical Advisory Board | N/A | N/A | N/A |
| Richard D. Yazbeck | Chief Technology Officer | N/A | N/A | N/A |
| Dr. Suman M. Verma M.D., Ph.D. | Chief Scientific Officer | N/A | N/A | N/A |
| Dr. Brian J. deGuzman M.D. | Chief Compliance Officer | N/A | N/A | 1965 |
| Mr. Michael A. Gordon | Gen. Counsel & Sec. | N/A | N/A | 1975 |
Description
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma (EAC). It offers EsoCheck, a cell collection device to prevent EAC deaths; and EsoGuard, an Esophageal DNA Test. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.
Corporate Governance
Lucid Diagnostics Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
